- Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas
-
Sung TY, Choi SH, Lee JM, Jeong JJ, Kang SW, Chung WY
- KMID: 2157915
- J Korean Med Sci.
- 2012 Jul;27(7):729-735.
- doi: 10.3346/jkms.2012.27.7.729
More than 95% of the thyroid carcinomas are well differentiated types showing favorable prognosis. However, only a few therapeutic options are available to treat the patients with undifferentiated thyroid carcinomas,... -
- CITED
-
- Close
- SHARE
-
- Close
